Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
In-Depth 14 is a branded generic ophthalmic lubricant developed and marketed by Austrak. It is formulated as an eye drop containing a combination of polyvinyl alcohol (1.4% w/v) and povidone (0.6% w/v). These active ingredients function as demulcents and lubricants that supplement the natural tear film, increasing its viscosity and stability on the ocular surface. By forming a protective coating, In-Depth 14 provides relief from symptoms of dry eye syndrome, such as irritation, burning, and foreign body sensation, and protects the eyes from further irritation due to environmental factors like wind or sun. The '14' in the product name refers to the 1.4% concentration of polyvinyl alcohol, a common strength for this type of ocular lubricant.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polyvinyl alcohol + povidone (Austrak).